Diebold Nixdorf AG : First signs of a reversal
Entry price | Target | Stop-loss | Potential |
---|
€70.67 |
€65 |
€71.28 |
+8.02% |
---|
Technical indicators currently hint at a trend reversal to the downside. As a result of this situation, new short positions could be open on the share Diebold Nixdorf AG.
Summary● In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
Strengths● Historically, the company has been releasing figures that are above expectations.
● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
● The tendency within the weekly time frame is positive above the technical support level at 68.7 EUR
Weaknesses● Technically, the stock approaches a strong medium-term resistance at EUR 71.28.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● For the past year, analysts have significantly revised downwards their profit estimates.
● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.